RetinalGenix Technologies Inc. (RTGN)
OTCMKTS · Delayed Price · Currency is USD
4.000
+0.800 (25.00%)
At close: May 4, 2026
RetinalGenix Technologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.03 | 0.01 | 0.01 | - | 0 | 0 |
Cash & Short-Term Investments | 0.03 | 0.01 | 0.01 | - | 0 | 0 |
Cash Growth | 3145.77% | 143.80% | - | - | -99.23% | 122.94% |
Total Current Assets | 0.03 | 0.01 | 0.01 | - | 0 | 0 |
Property, Plant & Equipment | 0 | 0 | 0.01 | 0 | 0 | - |
Other Long-Term Assets | 0 | 0 | 0 | - | - | - |
Total Assets | 0.03 | 0.02 | 0.01 | 0 | 0 | 0 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.17 | 1.08 | 0.92 | 0.88 | 0.48 | 0.25 |
Accrued Expenses | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0 |
Short-Term Debt | 0.05 | 0.54 | 0.52 | 0.51 | 0.16 | 0.07 |
Current Portion of Leases | 0 | 0 | 0 | - | - | - |
Other Current Liabilities | 1.43 | 0.67 | 0.02 | 0 | 0.43 | 0.14 |
Total Current Liabilities | 2.67 | 2.32 | 1.47 | 1.41 | 1.07 | 0.47 |
Long-Term Leases | 0 | 0 | 0.01 | - | - | - |
Total Liabilities | 2.67 | 2.32 | 1.48 | 1.41 | 1.07 | 0.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 16.11 | 15.68 | 14.12 | 9.7 | 7.95 | 4.64 |
Retained Earnings | -18.76 | -17.86 | -15.43 | -11.11 | -9.02 | -5.1 |
Comprehensive Income & Other | - | -0.13 | -0.15 | - | - | - |
Total Common Equity | -2.64 | -2.3 | -1.46 | -1.41 | -1.07 | -0.46 |
Shareholders' Equity | -2.64 | -2.3 | -1.46 | -1.41 | -1.07 | -0.46 |
Total Liabilities & Equity | 0.03 | 0.02 | 0.01 | 0 | 0 | 0 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.05 | 0.54 | 0.52 | 0.51 | 0.16 | 0.07 |
Net Cash (Debt) | -0.03 | -0.53 | -0.52 | -0.51 | -0.16 | -0.07 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.03 | -0.03 | -0.03 | -0.01 | -0.00 |
Filing Date Shares Outstanding | 18.84 | 18.75 | 18.52 | 17.79 | 17.27 | 14.28 |
Total Common Shares Outstanding | 18.84 | 18.75 | 18.52 | 17.64 | 17.27 | 14.22 |
Working Capital | -2.64 | -2.31 | -1.46 | -1.41 | -1.07 | -0.46 |
Book Value Per Share | -0.14 | -0.12 | -0.08 | -0.08 | -0.06 | -0.03 |
Tangible Book Value | -2.64 | -2.3 | -1.46 | -1.41 | -1.07 | -0.46 |
Tangible Book Value Per Share | -0.14 | -0.12 | -0.08 | -0.08 | -0.06 | -0.03 |
Machinery | - | - | 0 | 0 | 0 | - |